J. Martin Carroll - Jun 1, 2022 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
3
Date filed
6/1/2022, 04:20 PM
Previous filing
Dec 1, 2021
Next filing
Jun 3, 2022

No securities are beneficially owned.